Month: November 2021

A study from Washington University School of Medicine has identified an RNA molecule that suppresses prostate tumors. According to the research, restoring this so-called long noncoding RNA could be a new treatment strategy.

Washington University School of Medicine has received a $17 million grant from the National Institutes of Health (NIH) to address disparities in cancer research, treatment and outcomes in underrepresented populations.

Brandie Jefferson, senior news director for engineering and brain sciences in University Marketing & Communications, was one of three presenters on a recent panel at ScienceWriters2021, a joint meeting of the National Association of Science Writers and the Council for the Advancement of Science Writing.

At the university’s recent Board of Trustees meeting, numerous faculty members were appointed or promoted with tenure or granted tenure, with most new roles taking effect Oct. 1.

Through the innovative ‘Made to Model’ program, WashU students are producing, designing and creating formal fashion for St. Louis-area kids who might otherwise be overlooked.

The Washington University community is invited to watch a livestreamed conversation Nov. 9 between former first lady Michelle Obama and college students including WashU sophomore Natasha Chisholm. 

The McKelvey School of Engineering has launched a new Division of Engineering Education, headed by Jay Turner, to focus on world-class education for students and tools for faculty.

Abram Van Engen, professor of English in Arts & Sciences, has won the Peter J. Gomes Memorial Book Prize for “City on a Hill: A History of American Exceptionalism.”

The Mildred Lane Kemper Art Museum will present “Portrait, number 1 man (day clean ta sun down),” a two-day performance by artist Sheldon Scott, Nov. 18 and 19. An homage to Scott’s enslaved ancestors, the piece consists of the artist hulling and winnowing rice without break from sunrise to sunset.

A new study led by researchers at Washington University School of Medicine suggests that a widely used heart failure drug named sacubitril/valsartan is no better than valsartan alone in patients with severe heart failure.